642 related articles for article (PubMed ID: 22609220)
1. Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis Foundation.
Robinson A; Van Voorhees AS; Hsu S; Korman NJ; Lebwohl MG; Bebo BF; Kalb RE
J Am Acad Dermatol; 2012 Aug; 67(2):279-88. PubMed ID: 22609220
[TBL] [Abstract][Full Text] [Related]
2. Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation.
Rosenbach M; Hsu S; Korman NJ; Lebwohl MG; Young M; Bebo BF; Van Voorhees AS;
J Am Acad Dermatol; 2010 Apr; 62(4):655-62. PubMed ID: 19665821
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry.
Inzinger M; Heschl B; Weger W; Hofer A; Legat FJ; Gruber-Wackernagel A; Tilz H; Salmhofer W; Quehenberger F; Wolf P
Br J Dermatol; 2011 Sep; 165(3):640-5. PubMed ID: 21564068
[TBL] [Abstract][Full Text] [Related]
4. Review of treatment options for psoriasis in pregnant or lactating women: from the Medical Board of the National Psoriasis Foundation.
Bae YS; Van Voorhees AS; Hsu S; Korman NJ; Lebwohl MG; Young M; Bebo B; Kimball AB;
J Am Acad Dermatol; 2012 Sep; 67(3):459-77. PubMed ID: 22018758
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks.
Sivanesan SP; Gattu S; Hong J; Chavez-Frazier A; Bandow GD; Malick F; Kricorian G; Koo J
J Am Acad Dermatol; 2009 Nov; 61(5):793-8. PubMed ID: 19766350
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference.
Kalb RE; Strober B; Weinstein G; Lebwohl M
J Am Acad Dermatol; 2009 May; 60(5):824-37. PubMed ID: 19389524
[TBL] [Abstract][Full Text] [Related]
7. Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey.
Nijsten T; Margolis DJ; Feldman SR; Rolstad T; Stern RS
J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):434-44. PubMed ID: 15761421
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference.
Rosmarin DM; Lebwohl M; Elewski BE; Gottlieb AB;
J Am Acad Dermatol; 2010 May; 62(5):838-53. PubMed ID: 19932926
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of the preferences of patients with psoriasis between systemic psoralen plus ultraviolet A and bath psoralen plus ultraviolet A.
Alshiyab D; Chin MF; Edwards C; Anstey AV
Br J Dermatol; 2015; 172(5):1457-8. PubMed ID: 25420468
[No Abstract] [Full Text] [Related]
10. Treatment of psoriasis in patients with hepatitis C: from the Medical Board of the National Psoriasis Foundation.
Frankel AJ; Van Voorhees AS; Hsu S; Korman NJ; Lebwohl MG; Bebo BF; Gottlieb AB;
J Am Acad Dermatol; 2009 Dec; 61(6):1044-55. PubMed ID: 19811848
[TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical and cost-effectiveness of psoralen + ultraviolet A versus psoralen + sunlight in the treatment of chronic plaque psoriasis in a developing economy.
Aggarwal K; Khandpur S; Khanna N; Sharma VK; Pandav CS
Int J Dermatol; 2013 Apr; 52(4):478-85. PubMed ID: 23431966
[TBL] [Abstract][Full Text] [Related]
12. Systemic therapy does not usually clear psoriasis, but treatment success does not require clearing.
Feldman SR; Nijsten T; Margolis DJ; Rolstad T
J Am Acad Dermatol; 2005 Jan; 52(1):140-1. PubMed ID: 15627096
[No Abstract] [Full Text] [Related]
13. Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation.
Menon K; Van Voorhees AS; Bebo BF; Gladman DD; Hsu S; Kalb RE; Lebwohl MG; Strober BE;
J Am Acad Dermatol; 2010 Feb; 62(2):291-9. PubMed ID: 19646777
[TBL] [Abstract][Full Text] [Related]
14. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks.
Naldi L; Griffiths CE
Br J Dermatol; 2005 Apr; 152(4):597-615. PubMed ID: 15840088
[TBL] [Abstract][Full Text] [Related]
15. The Science and (Lost) Art of Psoralen Plus UVA Phototherapy.
Richard EG
Dermatol Clin; 2020 Jan; 38(1):11-23. PubMed ID: 31753184
[TBL] [Abstract][Full Text] [Related]
16. Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation.
Kalb RE; Bagel J; Korman NJ; Lebwohl MG; Young M; Horn EJ; Van Voorhees AS;
J Am Acad Dermatol; 2009 Jan; 60(1):120-4. PubMed ID: 19103363
[TBL] [Abstract][Full Text] [Related]
17. Psoralen and ultraviolet a light therapy for psoriasis.
Stern RS
N Engl J Med; 2007 Aug; 357(7):682-90. PubMed ID: 17699818
[No Abstract] [Full Text] [Related]
18. Psoralen plus ultraviolet A light phototherapy effectiveness.
Feldman SR
J Am Acad Dermatol; 2010 Oct; 63(4):718. PubMed ID: 20846573
[No Abstract] [Full Text] [Related]
19. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
[TBL] [Abstract][Full Text] [Related]
20. Treatment of nail psoriasis: best practice recommendations from the Medical Board of the National Psoriasis Foundation.
Crowley JJ; Weinberg JM; Wu JJ; Robertson AD; Van Voorhees AS;
JAMA Dermatol; 2015 Jan; 151(1):87-94. PubMed ID: 25471223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
